Jason E. Savage

3.3k citations

38 papers · 2.6k indexed · 2 hit papers · h-index 19

Impact in

Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Cancer Research top 5%
- MicroRNA in disease regulation

Papers in

Cancer Research 12
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 3
Cellular and Molecular Neuroscience 11
- Neurotransmitter Receptor Influence on Behavior 10

Co-authors: Bryan L. Roth Laura Rauser Sandra J. Hufeisen Michael H. Baumann Richard B. Rothman Nicole L. Simone David Gius Anthony D. Saleh
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Cell Cycle (3 papers)Cancer Research (3 papers)
Partner nations: United States Mexico Germany

In The Last Decade

Jason E. Savage

38 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress 2010 · 647 citations

Peers

Countries citing papers authored by Jason E. Savage

Since Specialization

Citations

This map shows the geographic impact of Jason E. Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Savage more than expected).

Fields of papers citing papers by Jason E. Savage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Savage. The network helps show where Jason E. Savage may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jason E. Savage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jason E. Savage Line = papers co-authored together Jason E. Savage links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	244MO A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer (“CLEVER”) Annals of Oncology ·Angela DeMichele, Amy S. Clark, Lauren J. Bayne, K. Rohn, Aneeba Amir, Paul Wileyto, Lindsay R. Berry, Stephanie DeLuca, Jason E. Savage, Igor Makhlin, Tony Pan, Jewell Graves, George K. Belka, Jiu‐Yao Wang, Natalie Shih, Donald A. Berry, Anupma Nayak, M. Feldman, Lewis A. Chodosh	2023	6
2	Transforming Standard of Care for Spine Surgery: Integration of an Online Single-Session Behavioral Pain Management Class for Perioperative Optimization SHILAP Revista de lepidopterología ·Sara Davin, Jason E. Savage, Wagner Claudio da Silva, Andrew Schuster, Beth D. Darnall	2022	15
3	Predicting Reciprocal Thoracic Change, Proximal Junctional Kyphosis, and Revision Surgery in Adult Spinal Deformity World Neurosurgery ·Meng Xiao-Jun, David S. Casper, 髙栁文貴, Luke Wooster, Jason E. Savage	2021	4
4	Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells International Journal of Radiation OncologyBiologyPhysics ·Gregor Manukian, N’Guessan Assiénin Hauverset, Tiziana DeAngelis, Anuradha A. Shastri, Jason E. Savage, Kevin Camphausen, Ulrich Rodeck, Jelani C. Zarif, Nicole L. Simone	2021	29
5	Dietary alterations modulate the microRNA 29/30 and IGF-1/AKT signaling axis in breast Cancer liver metastasis Nutrition & Metabolism ·Anuradha A. Shastri, Anthony D. Saleh, Jason E. Savage, Tiziana DeAngelis, Kevin Camphausen, Nicole L. Simone	2020	18
6	A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer Investigational New Drugs ·David B. Zhen, Kent A. Griffith, Vladislav S. Afanasyev, Kevin Camphausen, Jason E. Savage, Edward Kim, Vaibhav Sahai, Diane M. Simeone, Mark M. Zalupski	2016	27
7	Evaluation and Treatment of Spinal Metastatic Disease Cancer treatment and research ·Han Chang Dae, Jason E. Savage, Thomas J. Scharschmidt, Alpesh A. Patel	2014	8
8	The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster Breast Cancer Research and Treatment ·Lianjin Jin, Meng K. Lim, Shuping Zhao, Yuri Sano, Brittany A. Simone, Jason E. Savage, Eric Wickstrom, Kevin Camphausen, Richard G. Pestell, Nicole L. Simone	2014	35
9	Caloric restriction augments radiation efficacy in breast cancer Cell Cycle ·Anthony D. Saleh, Brittany A. Simone, Juan Palazzo, Jason E. Savage, Yuri Sano, Tu Dan, Lianjin Jin, Colin E. Champ, Shuping Zhao, Meng K. Lim, Federica Sotgia, Kevin Camphausen, Richard G. Pestell, John C. Mitchell, Michael P. Lisanti, Nicole L. Simone	2013	82
10	MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction Cell Cycle ·Ulf Andersson Ørom, Meng K. Lim, Jason E. Savage, Lianjin Jin, Anthony D. Saleh, Michael P. Lisanti, Nicole L. Simone	2012	35
11	Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53 PLoS ONE ·Anthony D. Saleh, Jason E. Savage, Liu Cao, Benjamin P. Soule, David Ly, William DeGraff, Curtis C. Harris, James B. Mitchell, Nicole L. Simone	2011	85
12	Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression PLoS ONE ·Nicole L. Simone, Benjamin P. Soule, David Ly, Anthony D. Saleh, Jason E. Savage, William DeGraff, John A. Cook, Curtis C. Harris, David Gius, James B. Mitchell	2009	275
13	l-Homocysteine Sulfinic Acid and Other Acidic Homocysteine Derivatives Are Potent and Selective Metabotropic Glutamate Receptor Agonists Journal of Pharmacology and Experimental Therapeutics ·Saaduldeen Ail Hussein, Jason E. Savage, Sandra J. Hufeisen, Laura Rauser, Ewa Grajkowska, Paul Ernsberger, Jarda T. Wroblewski, Joseph H. Nadeau, Bryan L. Roth	2003	90
14	In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs Psychopharmacology ·Veronika Butterweck, Adolf Nahrstedt, Momoka Horiuchi, Sandy Hufeisen, Laura Rauser, Jason E. Savage, 中小企業診断協会中小企業政策研究台チームMPA, Paul Ernsberger, Bryan L. Roth	2002	81
15	Rational design, synthesis, and biological evaluation of rigid pyrrolidone analogues as potential inhibitors of prostate cancer cell growth Bioorganic & Medicinal Chemistry Letters ·Lixin Qiao, Ajla Kasic, Qingjian Zhao, U. Klein, Shaomeng Wang, Teruhiko Fujii, Marcelo G. Kazanietz, Laura Rauser, Jason E. Savage, Bryan L. Roth, Judith Flippen‐Anderson, Alan P. Kozikowski	2001	29
16	Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor Bioorganic & Medicinal Chemistry Letters ·Richard B. Westkaemper, Scott P. Runyon, Jason E. Savage, Bryan Roth, Richard A. Glennon	2001	13
17	The in vitro pharmacology of the β-adrenergic receptor pet ligand ( s )-fluorocarazolol reveals high affinity for cloned β-adrenergic receptors and moderate affinity for the human 5-HT 1A receptor Psychopharmacology ·Bryan Roth, Paul Ernsberger, S Steinberg, 十九男桑波田, Laura Rauser, Jason E. Savage, Sandy Hufeisen, Marc S. Berridge, Raymond F. Muzic	2001	10
18	Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene Bioorganic & Medicinal Chemistry Letters ·Scott P. Runyon, Jason E. Savage, Cammie Edwards, Bryan Roth, Richard A. Glennon, Richard B. Westkaemper	2001	16
19	N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew Shideler, Maƚgorzata Dukat, Abdelmalik Slassi, Malysheva Ev, Lidia Demchyshyn, Jason E. Savage, Bryan L. Roth, B. Zizolfi, Mase Lee, Richard A. Glennon	2000	85
20	9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist European Journal of Pharmacology ·Richard B. Westkaemper, Scott P. Runyon, D. Rama, Jason E. Savage, Bryan L. Roth, Richard A. Glennon	1999	13

About Jason E. Savage

Jason E. Savage is a scholar working on Cancer Research, Cellular and Molecular Neuroscience, Aging, Biological Psychiatry and Molecular Biology, having authored 38 papers that have together received 2.6k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (10 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (3 papers), Spine and Intervertebral Disc Pathology (3 papers), Chemical synthesis and alkaloids (3 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Geriatrics and Gerontology (407 citations), Cancer Research (526 citations), Cellular and Molecular Neuroscience (553 citations), Aging (46 citations) and Molecular Biology (1.3k citations). Jason E. Savage has collaborated with scholars based in United States, Mexico and Germany. Frequent co-authors include Bryan L. Roth, Laura Rauser, Sandra J. Hufeisen, Michael H. Baumann, Richard B. Rothman, Nicole L. Simone, David Gius, Anthony D. Saleh, Richard A. Glennon and James B. Mitchell. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, International Journal of Radiation Oncology*Biology*Physics, Journal of Pharmacology and Experimental Therapeutics, Cell Cycle and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact